AIFF Firefly Neuroscience, Inc.
TechnologyAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
3.36
P/S
17.20
EV/EBITDA
-2.76
DCF Value
$-0.13
FCF Yield
-28.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.0%
Operating Margin
-539.8%
Net Margin
-565.4%
ROE
-94.7%
ROA
-82.1%
ROIC
-101.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $485.0K | $-2.0M | $— |
| Q4 null | $412.0K | $-2.5M | $— |
| FY null | $1.1M | $-19.9M | $— |
| Q3 null | $388.0K | $-2.6M | $— |
Analyst Ratings
View AllConsensus
—
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
View AllCompany Info
Sector
Technology
Industry
Software - Application
Country
CA
Exchange
—
Beta
0.60
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.